Clinical implication of denervation in sporadic inclusion body myositis

J Neurol Sci. 2022 Aug 15:439:120317. doi: 10.1016/j.jns.2022.120317. Epub 2022 Jun 8.

Abstract

Introduction: Sporadic inclusion body myositis (sIBM) is often accompanied by signs suggestive of denervation on electromyography (EMG), which mimics neurogenic disorders. Hence, the current study aimed to assess reinnervation after denervation in sIBM and its clinical impllcation.

Methods: We retrospectively examined consecutive muscle biopsy specimens collected from 109 sIBM patients who were referred to our institution for diagnostic muscle biopsy from 2001 to 2018. Reinnervation after denervation in sIBM patients was assessed via muscle biopsy and EMG. The levels of acetylcholine receptor subunit γ (Chrng) and muscle-specific kinase (MuSK) mRNA, which are markers of denervation, were examined using real-time polymerase chain reaction. Response to treatment was defined as an increase of grade 1 or higher in two or more muscle groups as assessed using the Medical Research Council scale.

Results: In total, 93 (85.3%) of 109 sIBM patients had reinnervation after denervation on histological examination and/or EMG. The mean disease duration before biopsy was significantly longer in patients with reinnervation after denervation than in those without (p < 0.00001). Patients with denervation had significantly higher levels of Chrng and MuSK mRNA than those without. The proportion of patients who responded to immunosuppressive therapies was smaller in the patients with denervation than those without (p < 0.05). However, there was no significant difference regarding time from onset to using a walking aid between the two groups.

Discussion: Reinnervation after denervation is associated with disease duration and short-term response to therapy in individuals with sIBM.

Keywords: Denervation; Muscle biopsy; Prognosis; Sporadic inclusion body myositis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Denervation
  • Electromyography
  • Humans
  • Myositis, Inclusion Body* / diagnosis
  • RNA, Messenger
  • Retrospective Studies

Substances

  • RNA, Messenger